Similarly, while stimulation of glioma cells with soluble DLK1 boosted the increase in the expression of the stem cell marker genes NANOG, OCT4, and SOX2 in hypoxic cells, addition of PT2385 blocked this specific DLK1 effect in all cell lines tested (Figure 6B). The gene discussed is NANOG; the disease is central nervous system cancer.